Wednesday, July 8, 2026
🇺🇸 FDA

pharma · HIV-1 Infection · HIV-1 infection

Gilead Sciences

Gilead Sciences Pty Limited

Gilead Sciences trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
TGA registrant Type
Company details
Status
Public
HQ
333 Lakeside Drive, Foster City, CA 94404, US
Founded
1987
Employees
14,602
Programs
30
Drugs
54
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Gilead Sciences clinical trials

Registry index of 30 ClinicalTrials.gov studies linked to Gilead Sciences programs — each row shows trial ID, program name, phase, status, and indication.

Gilead Sciences trial registry — 30 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Gilead Sciences.

  1. IMMU-132-06 — Phase 2

    Clinical update

  2. EDGE-Lung — Phase 2

    Clinical update

  3. IMMU-132-13 — Phase 3

    Clinical update

  4. GS-US-699-7184-01 — Phase 2

    Clinical update

  5. GS-US-695-7156 — Phase 3

    Clinical update

  6. GS-US-695-6509 — Phase 3

    Clinical update

  7. GS-US-682-6769 — Phase 3

    Clinical update

  8. GS-US-626-6216 — Phase 3

    Clinical update

Trial registry

30 studies
  4. 2023-504195-14-00

    GS-US-592-6238

    Phase 3 active small_molecule

    PD-L1-negative metastatic triple-negative breast cancer or PD-L1-positive metastatic triple-negative breast cancer previously treated with an anti-PD-(L)1 agent in the curative setting

    CTIS ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.